Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 128

1.

The potential impact of an HIV vaccine with limited protection on HIV incidence in Thailand: a modeling study.

Nagelkerke NJ, Hontelez JA, de Vlas SJ.

Vaccine. 2011 Aug 18;29(36):6079-85. doi: 10.1016/j.vaccine.2011.06.048. Epub 2011 Jun 28.

PMID:
21718745
2.

The potential impact of a moderately effective HIV vaccine with rapidly waning protection in South Africa and Thailand.

Andersson KM, Stover J.

Vaccine. 2011 Aug 18;29(36):6092-9. doi: 10.1016/j.vaccine.2011.06.060. Epub 2011 Jun 22.

PMID:
21703322
3.

Expected epidemiological impact of the introduction of a partially effective HIV vaccine among men who have sex with men in Australia.

Gray RT, Ghaus MH, Hoare A, Wilson DP.

Vaccine. 2011 Aug 18;29(36):6125-9. doi: 10.1016/j.vaccine.2011.06.061. Epub 2011 Jun 22.

PMID:
21703320
4.

Expected epidemiological impacts of introducing an HIV vaccine in Thailand: a model-based analysis.

Schneider K, Kerr CC, Hoare A, Wilson DP.

Vaccine. 2011 Aug 18;29(36):6086-91. doi: 10.1016/j.vaccine.2011.06.074. Epub 2011 Jul 1.

PMID:
21723902
5.

The potential impact of RV144-like vaccines in rural South Africa: a study using the STDSIM microsimulation model.

Hontelez JA, Nagelkerke N, Bärnighausen T, Bakker R, Tanser F, Newell ML, Lurie MN, Baltussen R, de Vlas SJ.

Vaccine. 2011 Aug 18;29(36):6100-6. doi: 10.1016/j.vaccine.2011.06.059. Epub 2011 Jun 22.

6.

The cost-effectiveness of a modestly effective HIV vaccine in the United States.

Long EF, Owens DK.

Vaccine. 2011 Aug 18;29(36):6113-24. doi: 10.1016/j.vaccine.2011.04.013. Epub 2011 Apr 19.

7.

The potential impact of an HIV vaccine with rapidly waning protection on the epidemic in Southern Africa: examining the RV144 trial results.

Andersson KM, Paltiel AD, Owens DK.

Vaccine. 2011 Aug 18;29(36):6107-12. doi: 10.1016/j.vaccine.2011.06.076. Epub 2011 Jul 5.

8.

Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand.

Rerks-Ngarm S, Pitisuttithum P, Nitayaphan S, Kaewkungwal J, Chiu J, Paris R, Premsri N, Namwat C, de Souza M, Adams E, Benenson M, Gurunathan S, Tartaglia J, McNeil JG, Francis DP, Stablein D, Birx DL, Chunsuttiwat S, Khamboonruang C, Thongcharoen P, Robb ML, Michael NL, Kunasol P, Kim JH; MOPH-TAVEG Investigators..

N Engl J Med. 2009 Dec 3;361(23):2209-20. doi: 10.1056/NEJMoa0908492. Epub 2009 Oct 20.

10.

Update on HIV/AIDS in Thailand.

Ruxrungtham K, Phanuphak P.

J Med Assoc Thai. 2001 Jun;84 Suppl 1:S1-17. Review.

PMID:
11529320
11.

Preventive HIV vaccine acceptability and behavioral risk compensation among high-risk men who have sex with men and transgenders in Thailand.

Newman PA, Roungprakhon S, Tepjan S, Yim S.

Vaccine. 2010 Jan 22;28(4):958-64. doi: 10.1016/j.vaccine.2009.10.142. Epub 2009 Nov 17.

PMID:
19925897
12.
13.

How low can you go: the impact of a modestly effective HIV vaccine compared with male circumcision.

Kaldor JM, Wilson DP.

AIDS. 2010 Oct 23;24(16):2573-8. doi: 10.1097/QAD.0b013e32833ead96.

PMID:
20829677
14.
15.

HIV-1 prophylactic vaccine trials in Thailand.

Pitisuttithum P.

Curr HIV Res. 2005 Jan;3(1):17-30. Review.

PMID:
15638720
16.

The potential global market size and public health value of an HIV-1 vaccine in a complex global market.

Marzetta CA, Lee SS, Wrobel SJ, Singh KJ, Russell N, Esparza J.

Vaccine. 2010 Jul 5;28(30):4786-97. doi: 10.1016/j.vaccine.2010.04.098. Epub 2010 May 14.

PMID:
20471439
17.

Feasibility of a preventive HIV-1 vaccine cohort among persons attending sexually transmitted disease clinics in Thailand.

Markowitz LE, Sirisopana N, Charonwatanachokchai A, Julvanichpong W, Siraprapasiri T, Palanuvej T, Siriwongrangsun P, Tungsakul V, Pumratana K, Chitwarakorn A, Michael RA, Brown AE.

J Acquir Immune Defic Syndr Hum Retrovirol. 1999 Apr 15;20(5):488-94.

PMID:
10225232
18.

Cost effectiveness and delivery study for future HIV vaccines.

Barth-Jones DC, Cheng H, Kang LY, Kenya PR, Odera D, Mosqueira NR, Mendoza W, Portela MC, Brito C, Tangcharoensathien V, Akaleephan C, Supantamart S, Patcharanarumol W, de Macedo Brigido LF, Fonseca MG, Sanchez M, Chang ML, Osmanov S, Avrett S, Esparza J, Griffiths U; WHO-UNAIDS collaborative group on cost-effectiveness, delivery and future access to HIV vaccines..

AIDS. 2005 Sep 2;19(13):w1-6.

PMID:
16103763
19.

Phase III HIV vaccine trial in Thailand: a step toward a protective vaccine for HIV.

Vaccari M, Poonam P, Franchini G.

Expert Rev Vaccines. 2010 Sep;9(9):997-1005. doi: 10.1586/erv.10.104. Review.

PMID:
20822342
20.

Feasibility of northern Thai factory workers as participants in HIV vaccine trials.

Natpratan C, Nantakwang D, Beyrer C, Kunawararak P, Gunhom C, Celentano DD, Nelson KE, Khamboonruang C.

Southeast Asian J Trop Med Public Health. 1996 Sep;27(3):457-62.

PMID:
9185253

Supplemental Content

Support Center